FDA Adverse Event Malfunction Summary report: N

SYNCHROMED II

MDR report key: 4650398 · Received April 1, 2015

Report

Report Number
3007566237-2015-00847
Event Type
Malfunction
Date Received
April 1, 2015
Report Date
March 11, 2015
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
LKK
PMA / PMN Number
P860004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CONCOMITANT MEDICAL PRODUCTS: PRODUCT ID: 8578, LOT# N150639, IMPLANTED: (B)(6) 2008, PRODUCT TYPE: ACCESSORY. PRODUCT ID: 8709, LOT# J11193R06, IMPLANTED: (B)(6) 2002, PRODUCT TYPE: CATHETER. PRODUCT ID: 8840, PRODUCT TYPE: PROGRAMMER, PHYSICIAN. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT WAS "VERY, VERY SPASTIC" AND HAD A CHANGE IN THERAPY EFFECT BEGINNING LAST WEEK. THE PATIENT WAS SEEN ON THE DATE OF THIS REPORT FOR A DOSAGE INCREASE. WHEN THE HEALTHCARE PROFESSIONAL (HCP) INTERROGATED THE PUMP, THE CLINICIAN PROGRAMMER SHOWED THE FOLLOWING PUMP MESSAGE; "THERAPY STOPPED INACTIVE USE MINIMUM RATE INFUSION MODE". THE HCP THOUGHT "MAYBE SINCE ELECTIVE REPLACEMENT INDICATOR (ERI) [WAS] IN 2 MONTHS, THE PUMP STARTING TO FAIL". IT WAS NOTED THERE WERE NO STALL IN THE PUMP LOGS AND NOTHING ELSE IN THE LOGS TO INDICATED A PROBLEM. THE HCP CONFIRMED IT WAS POSSIBLE THEY HIT THE RED THERAPY STOP BUTTON ON THEIR PROGRAMMER. THE HCP WAS ABLE TO SUCCESSFULLY NAVIGATE OUT OF "THIS" SCREEN AND IT RESOLVED THE ISSUE. THE PUMP WAS UPDATED WITHOUT A PROBLEM, THE DOSAGE WAS INCREASED TO 739.4 MCG/DAY AND THE PATIENT WAS GIVEN ORAL BACLOFEN TO USE AS NEEDED. THE PATIENT'S MOTHER REPORTED THE PATIENT HAD IMPROVED AND DID NOT NEED THE ORAL BACLOFEN. THE PATIENT WOULD RETURN ON (B)(6) /2015 FOR A ROUTINE PUMP REFILL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
214643 SYNCHROMED II PUMP, INFUSION, IMPLANTED, PROGRAMMABLE LKK MEDTRONIC NEUROMODULATION 8637-40

Patients

Seq Age Sex Outcome Treatment
1 00023 YR